The use of serial measurement of plasma cholinesterase in the management of acute poisoning with organophosphates and carbamates

Forensic Science International

Volumn 162, Issue 1-3, 2006, Pages 126-130

  Abdullat, I M ^b   Battah, A H ^b   Hadidi, K A ^a,b  

^a JORDAN UNIVERSITY HOSPITAL   (Jordan)

^b THE UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Butyrylcholinesterase; Carbamate; Organophosphate; Serial measurements

Indexed keywords

ATROPINE; CARBAMATE INSECTICIDE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; ORGANOPHOSPHATE INSECTICIDE; PRALIDOXIME;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLINESTERASE BLOOD LEVEL; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG INTOXICATION; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; INSECTICIDAL ACTIVITY; INTOXICATION; MALE; PRIORITY JOURNAL; PROGNOSIS; SERIAL MEASUREMENT; SYMPTOMATOLOGY;

EID: 33748558741     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2006.06.074     Document Type: Article

References (23)

1. Saadeh A.M., Al-Ali M.K., Farsakh N.A., and Ghani M.A. Clinical and sociodemographic features of acute carbamate and organophosphate poisoning: a study of 70 adult patients in north Jordan. J. Toxicol. Clin. Toxicol. 34 1 (1996) 45-51
2. Garcia-Repetto R., Soria M.L., Gimenez M.P., Menendez M., and Repetto M. Deaths from pesticide poisoning in Spain from 1991 to 1996. Vet. Hum. Toxicol. 40 3 (1998) 166-168
3. Lifshitz M., Shahak E., and Sofer S. Carbamate and organophosphate poisoning in young children. Pediatr. Emerg. Care 15 2 (1999) 102-103
4. Peter J.V., and Cherian A.M. Organic insecticides. Anaesth. Intensive Care 28 1 (2000) 11-21
5. Dong X., and Simon M.A. The epidemiology of organophosphate poisoning in urban Zimbabwe from 1995 to 2000. Int. J. Occup. Environ. Health 7 4 (2001) 333-338
6. Abu Al-Ragheb S.Y., and Salhab A.S. Pesticide mortality, a Jordanian experience. Am. J. Forensic Med. Pathol. 10 3 (1989) 221-225
7. Ellenhorn M.J. Pesticides. In: Ellenhorn M.J. (Ed). Ellenhorn's Medical Toxicology Diagnosis and Treatment of Human Poisoning. second ed. (1997), William and Wilkins, Baltimore, USA 1614-1663
8. Coye M.J., Barnett P.G., Midtling J.E., Velasco A.R., Romero P., Clements C.L., and Rose T.G. Clinical confirmation of organophosphate poisoning by serial cholinesterase analyses. Arch. Intern. Med. 147 3 (1987) 438-442
9. Lee P., and Tai D.Y. Clinical features of patients with acute organophosphate poisoning requiring intensive care. Intensive Care Med. 27 4 (2001) 694-699
10. Yamashita M., Tanaka J., and Ando Y. Human mortality in organophosphate poisonings. Vet. Hum. Toxicol. 39 2 (1997) 84-85
11. Lessenger J.E., and Reese B.E. Rational use of cholinesterase activity testing in pesticide poisoning. J. Am. Board Fam. Pract. 12 4 (1999) 307-314
12. Trundle D., and Marcial G. Detection of cholinesterase inhibition. The significance of cholinesterase measurement. Ann. Clin. Lab. Sci. 18 5 (1988) 345-352
13. Aygun D., Doganay Z., Altintop L., Guven H., Onar M., Deniz T., and Sunter T. Serum acetylcholinesterase and prognosis of acute organophosphate poisoning. J. Toxicol. Clin. Toxicol. 40 7 (2002) 903-910
14. Dyer S.M., Cattani M., Pisaniello D.L., Williams F.M., and Edwards J.W. Peripheral cholinesterase inhibition by occupational chlorpyrifos exposure in Australian termiticide applicators. Toxicol 169 3 (2001) 177-185
15. Persson H.E., Sjoberg G.K., Haines J.A., and Pronczuk de Garbino J. Poisoning severity score. Grading of acute poisoning. J. Toxicol. Clin. Toxicol. 36 3 (1998) 205-213
16. Thiermann H., Mast U., Klimmek R., Eyer P., Hibler A., Pfab R., Felgenhauer N., and Zilker T. Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients. Hum. Exp. Toxicol. 16 8 (1997) 473-480
17. Singh S., Chaudhry D., Behera D., Gupta D., and Jindal S.K. Aggressive atropinisation and continuous pralidoxime (2-PAM) in patients with severe organophosphate poisoning: experience of a northwest Indian hospital. Hum. Exp. Toxicol. 20 1 (2001) 15-18
18. Schexnayder S., James L.P., Kearns G.L., and Farrar H.C. The pharmacokinetics of continuous infusion pralidoxime in children with organophosphate poisoning. J. Toxicol. Clin. Toxicol. 36 6 (1998) 549-555
19. Worek F., Backer M., Thiermann H., Szinicz L., Mast U., Klimmek R., and Eyer P. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum. Exp. Toxicol. 16 8 (1997) 466-472
20. Tush G.M., and Anstead M.I. Pralidoxime continuous infusion in the treatment of organophosphate poisoning. Ann. Pharmacother. 31 4 (1997) 441-444
21. Van Helden H.P., Busker R.W., Melchers B.P., and Bruijnzeel P.L. Pharmacological effects of oximes: how relevant are they?. Arch. Toxicol. 70 12 (1996) 779-786
22. Thiermann H., Szinicz L., Eyer F., Worek F., Eyer P., Felgenhauer N., and Zilker T. Modern strategies in therapy of organophosphate poisoning. Toxicol. Lett. 107 1-3 (1999) 233-239
23. Surjit S., and Sharma N. Neurological syndromes following organophosphate poisoning. Neurol. India 48 (2000) 308-313